Eric J Chow1,2, Melissa A Rolfes2, Ruth L Carrico3, Stephen Furmanek3, Julio A Ramirez3, Jill M Ferdinands2, Alicia M Fry2, Manish M Patel2. 1. Epidemic Intelligence Service, Center for Surveillance, Epidemiology and Laboratory Services, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. 2. Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. 3. Division of Infectious Diseases, University of Louisville School of Medicine, Louisville, Kentucky, USA.
Abstract
BACKGROUND: Preventing severe complications of influenza such as hospitalization is a public health priority; however, estimates of influenza vaccine effectiveness (VE) against influenza-associated acute lower respiratory tract infection (LRTI) hospitalizations are limited. We examined influenza VE against influenza-associated LRTIs in hospitalized adult patients. METHODS: We retrospectively analyzed data from a randomized trial of oseltamivir treatment in adults hospitalized with LRTI in Louisville, Kentucky, from 2010 to 2013. Patients were systematically tested for influenza at the time of enrollment. We estimated VE as 1 - the adjusted odds ratio (aOR) of antecedent vaccination in influenza-positives vs negatives × 100%. Vaccination status was obtained by patient self-report. Using logistic regression adjusting for age, sex, season, timing of illness, history of chronic lung disease, and activities of daily living, we estimated VE against hospitalized influenza-associated LRTIs and community-acquired pneumonia (CAP) with radiographic findings of infiltrate. RESULTS: Of 810 patients with LRTI (median age, 62 years), 184 (23%) were influenza-positive and 57% had radiographically confirmed CAP. Among influenza-positives and -negatives, respectively, 61% and 69% were vaccinated. Overall, 29% were hospitalized in the prior 90 days and >80% had comorbidities. Influenza-negatives were more likely to have a history of chronic obstructive pulmonary disease than influenza-positives (59% vs 48%; P = .01), but baseline medical conditions were otherwise similar. Overall, VE was 35% (95% CI, 4% to 56%) against influenza-associated LRTI and 51% (95% CI, 13% to 72%) against influenza-associated radiographically confirmed CAP. CONCLUSIONS: Vaccination reduced the risk of hospitalization for influenza-associated LRTI and radiographically confirmed CAP. Clinicians should maintain high rates of influenza vaccination to prevent severe influenza-associated complications. Published by Oxford University Press on behalf of Infectious Diseases Society of America 2020.
BACKGROUND: Preventing severe complications of influenza such as hospitalization is a public health priority; however, estimates of influenza vaccine effectiveness (VE) against influenza-associated acute lower respiratory tract infection (LRTI) hospitalizations are limited. We examined influenza VE against influenza-associated LRTIs in hospitalized adult patients. METHODS: We retrospectively analyzed data from a randomized trial of oseltamivir treatment in adults hospitalized with LRTI in Louisville, Kentucky, from 2010 to 2013. Patients were systematically tested for influenza at the time of enrollment. We estimated VE as 1 - the adjusted odds ratio (aOR) of antecedent vaccination in influenza-positives vs negatives × 100%. Vaccination status was obtained by patient self-report. Using logistic regression adjusting for age, sex, season, timing of illness, history of chronic lung disease, and activities of daily living, we estimated VE against hospitalized influenza-associated LRTIs and community-acquired pneumonia (CAP) with radiographic findings of infiltrate. RESULTS: Of 810 patients with LRTI (median age, 62 years), 184 (23%) were influenza-positive and 57% had radiographically confirmed CAP. Among influenza-positives and -negatives, respectively, 61% and 69% were vaccinated. Overall, 29% were hospitalized in the prior 90 days and >80% had comorbidities. Influenza-negatives were more likely to have a history of chronic obstructive pulmonary disease than influenza-positives (59% vs 48%; P = .01), but baseline medical conditions were otherwise similar. Overall, VE was 35% (95% CI, 4% to 56%) against influenza-associated LRTI and 51% (95% CI, 13% to 72%) against influenza-associated radiographically confirmed CAP. CONCLUSIONS: Vaccination reduced the risk of hospitalization for influenza-associated LRTI and radiographically confirmed CAP. Clinicians should maintain high rates of influenza vaccination to prevent severe influenza-associated complications. Published by Oxford University Press on behalf of Infectious Diseases Society of America 2020.
Authors: Jill M Ferdinands; Manjusha Gaglani; Emily T Martin; Don Middleton; Arnold S Monto; Kempapura Murthy; Fernanda P Silveira; H Keipp Talbot; Richard Zimmerman; Elif Alyanak; Courtney Strickland; Sarah Spencer; Alicia M Fry Journal: J Infect Dis Date: 2019-09-13 Impact factor: 5.226
Authors: Jørgen Vestbo; Suzanne S Hurd; Alvar G Agustí; Paul W Jones; Claus Vogelmeier; Antonio Anzueto; Peter J Barnes; Leonardo M Fabbri; Fernando J Martinez; Masaharu Nishimura; Robert A Stockley; Don D Sin; Roberto Rodriguez-Roisin Journal: Am J Respir Crit Care Med Date: 2012-08-09 Impact factor: 21.405
Authors: Sunita Mulpuru; Li Li; Lingyun Ye; Todd Hatchette; Melissa K Andrew; Ardith Ambrose; Guy Boivin; William Bowie; Ayman Chit; Gael Dos Santos; May ElSherif; Karen Green; Francois Haguinet; Scott A Halperin; Barbara Ibarguchi; Jennie Johnstone; Kevin Katz; Joanne M Langley; Jason LeBlanc; Mark Loeb; Donna MacKinnon-Cameron; Anne McCarthy; Janet E McElhaney; Allison McGeer; Jeff Powis; David Richardson; Makeda Semret; Vivek Shinde; Daniel Smyth; Sylvie Trottier; Louis Valiquette; Duncan Webster; Shelly A McNeil Journal: Chest Date: 2019-01 Impact factor: 9.410
Authors: Shekhar Ghamande; Courtney Shaver; Kempapura Murthy; Chandni Raiyani; Heath D White; Tasnim Lat; Alejandro C Arroliga; Dayna Wyatt; H Keipp Talbot; Emily T Martin; Arnold S Monto; Richard K Zimmerman; Donald B Middleton; Fernanda P Silveira; Jill M Ferdinands; Manish M Patel; Manjusha Gaglani Journal: Clin Infect Dis Date: 2022-04-28 Impact factor: 20.999
Authors: Eric J Chow; Mark W Tenforde; Melissa A Rolfes; Benjamin Lee; Shreya Chodisetty; Julio A Ramirez; Alicia M Fry; Manish M Patel Journal: PLoS One Date: 2021-10-21 Impact factor: 3.240